The first NOAC with
a reversal agent
a reversal agent
YOUR FORESIGHT.
HIS FUTURE.
Dabigatran etexilate (Pradaxa®) is proven to be safe and effective to lower the risk of stroke and gives you the assurance of reversibility with Idarucizumab (Praxbind®) in emergency situations.
Pradaxa Reimbursement 2021
Document ID: PC-ZA-101354
02/07/2021
Author: Boehringer Ingelheim
Related content
PC-ZA-101354
Production date: July 2021
Production date: July 2021